Literature DB >> 22489910

Spirometric thresholds for diagnosing COPD: 0.70 or LLN, pre- or post-dilator values?

Firdaus A A Mohamed Hoesein1, Pieter Zanen, Alfred P E Sachs, Theo J M Verheij, Jan-Willem J Lammers, Berna D L Broekhuizen.   

Abstract

In absence of a gold standard for chronic obstructive pulmonary disease (COPD) it remains difficult to compare the true diagnostic characteristics of the forced expiratory volume in 1 second to the forced vital capacity (FEV(1)/FVC) <0.70 and < lower limit of normal (LLN). COPD is a clinical diagnosis, based on symptoms signs and lung function results combined, and an expert panel assessment would be an adequate reference standard. We compared the diagnostic properties of FEV(1)/FVC <LLN and <0.70 against this panel diagnosis: 342 participants, aged >50, consulting for persistent cough, but without physician-diagnosed COPD, were prospectively enrolled. All underwent extensive history taking, physical examination, spirometry and diffusion testing. An expert panel, including a board certified respiratory physician, assessed all diagnostic information to determine the presence or absence of COPD and served as reference standard. Then, 104 participants were diagnosed with COPD by the panel. The reproducibility of the panel diagnosis was high (kappa of 0.94). Sensitivity estimates of <0.70 were significantly higher than that of <LLN (0.73 and 0.47, respectively, p < 0.001). The fixed approach was less specific than the LLN (0.95 and 0.99, respectively, p < 0.001). There was no significant difference in diagnostic property when using pre- or post-bronchodilator FEV(1)/FVC (p = 0.615). In a symptomatic primary care population, the FEV(1)/FVC <0.70 was more accurate to detect COPD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22489910     DOI: 10.3109/15412555.2012.667851

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  8 in total

1.  The ability of volumetric capnography to distinguish between chronic obstructive pulmonary disease patients and normal subjects.

Authors:  Guang-Sheng Qi; Wen-Chao Gu; Wen-Lan Yang; Feng Xi; Hao Wu; Jin-Ming Liu
Journal:  Lung       Date:  2014-07-15       Impact factor: 2.584

2.  Prevalence, Characteristics, and Prognosis of Early Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study.

Authors:  Yunus Çolak; Shoaib Afzal; Børge G Nordestgaard; Jørgen Vestbo; Peter Lange
Journal:  Am J Respir Crit Care Med       Date:  2020-03-15       Impact factor: 21.405

3.  Prevalence and Population Attributable Risk for Early Chronic Obstructive Pulmonary Disease in U.S. Hispanic/Latino Individuals.

Authors:  Fariha Khalid; Wei Wang; David Mannino; Alejandro A Diaz
Journal:  Ann Am Thorac Soc       Date:  2022-03

Review 4.  Diagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: the finnish guidelines.

Authors:  Hannu Kankaanranta; Terttu Harju; Maritta Kilpeläinen; Witold Mazur; Juho T Lehto; Milla Katajisto; Timo Peisa; Tuula Meinander; Lauri Lehtimäki
Journal:  Basic Clin Pharmacol Toxicol       Date:  2015-01-22       Impact factor: 4.080

5.  Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.

Authors: 
Journal:  Lancet Respir Med       Date:  2017-08-16       Impact factor: 30.700

6.  Can spirometric norms be set using pre- or post- bronchodilator test results in older people?

Authors:  Bernet Kato; Amund Gulsvik; William Vollmer; Christer Janson; Michael Studnika; Sonia Buist; Peter Burney
Journal:  Respir Res       Date:  2012-11-16

7.  Computed tomography structural lung changes in discordant airflow limitation.

Authors:  Firdaus A A Mohamed Hoesein; Pim A de Jong; Jan-Willem J Lammers; Willem Pthm Mali; Michael Schmidt; Harry J de Koning; Carlijn van der Aalst; Matthijs Oudkerk; Rozemarijn Vliegenthart; Bram van Ginneken; Eva M van Rikxoort; Pieter Zanen
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

Review 8.  Use of expert panels to define the reference standard in diagnostic research: a systematic review of published methods and reporting.

Authors:  Loes C M Bertens; Berna D L Broekhuizen; Christiana A Naaktgeboren; Frans H Rutten; Arno W Hoes; Yvonne van Mourik; Karel G M Moons; Johannes B Reitsma
Journal:  PLoS Med       Date:  2013-10-15       Impact factor: 11.069

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.